Asset Dedication LLC’s Calithera Biosciences, Inc CALA Stock Holding History

Asset Dedication LLC’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-300	Closed	-$30K	–	807
2020 Q4	$30K	Hold	300	–	–	0.01%	414
2020 Q3	$20K	Hold	300	–	–	﹤0.01%	453
2020 Q2	$32K	Hold	300	–	–	0.01%	352
2020 Q1	$26K	Hold	300	–	–	0.01%	372
2019 Q4	$34K	Hold	300	–	–	0.01%	335
2019 Q3	$18K	Hold	300	–	–	0.01%	400
2019 Q2	$24K	Hold	300	–	–	0.01%	351
2019 Q1	$40K	Hold	300	–	–	0.01%	297
2018 Q4	$24K	Sell	300 -360	-55%	-$35.5K	0.01%	335
2018 Q3	$70K	Hold	660	–	–	0.03%	238
2018 Q2	$66K	Buy	+660	New	+$74.8K	0.02%	237

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Asset Dedication LLC's CALA Position: Q1 2021 in Review

Asset Dedication LLC sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 300 shares — an estimated $30K sold.

Asset Dedication LLC first reported a position in CALA in Q2 2018 and held it in 11 quarters. The position peaked at $70K in Q3 2018. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

Asset Dedication LLC reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
Asset Dedication LLC sold 300 Calithera Biosciences, Inc shares in Q1 2021, an estimated $30K.
Asset Dedication LLC first reported a position in Calithera Biosciences, Inc in Q2 2018 and held it in 11 quarters.
Asset Dedication LLC's Calithera Biosciences, Inc position peaked at $70K in Q3 2018.
100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on Asset Dedication LLC's 13F filing for Q1 2021, filed 3 May 2021.